Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Semaglutide: Monthly plan: $249/month, with the first month at $209 Quarterly plan: $199/month billed every three months, with the first month at $159 when paid in full Tirzepatide: Monthly plan: $315/month, with the first month at $275 Quarterly plan: $275/month billed every three months, with the first month at $235 when paid in full All plans include medication, 24/7 physician access, meal plans, nutrition guidance, progress tracking, and free expedited shipping
Known under branded names such as Wegovy, recognized exclusively for weight management, and Ozempic, approved for type 2 diabetes treatment, semaglutide offers multiple avenues for health improvement
Chemical First Aid & Decontamination Solutions Specialist solutions for chemical incidents, burns and spills Preventing Serious Chemical Harm Helping organisations respond quickly and effectively to hazardous chemical incidents
Aucatzyla, a CD19-directed CAR-T therapy, received approval on November 8, 2024, for treating adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (BCP-ALL)
Priority access to your provider for sick visits, quarterly lab panels, personalized wellness plans, and bi-annual advanced labs that are exclusively available through our Wellness Concierge membership tiers
"I think that this entire thing has been a bit misleading," says Caitee Donovan, referring to a White House press conference Monday in which Trump and his deputies blamed Tylenol for autism and encouraged the use of leucovorin to treat it
